
    
      A Phase I, Randomized, DoubleBlind Placebo-Controlled Study to Investigate the Safety,
      Tolerability and Pharmacokinetics of Multiple Ascending Inhaled Doses (MAD) of AZD7624 to
      Healthy Subjects and Patients with COPD
    
  